nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—pancreatic cancer—liver cancer	0.362	1	CtDrD
Tamoxifen—DHCR7—Epirubicin—liver cancer	0.123	0.426	CbGbCtD
Tamoxifen—ESR1—liver cancer	0.0762	0.383	CbGaD
Tamoxifen—DHCR7—Doxorubicin—liver cancer	0.0656	0.227	CbGbCtD
Tamoxifen—CYP2E1—liver cancer	0.0617	0.311	CbGaD
Tamoxifen—CYP1A1—liver cancer	0.0609	0.306	CbGaD
Tamoxifen—ABCB11—bile canaliculus—liver cancer	0.0131	0.349	CbGeAlD
Tamoxifen—CYP1B1—Doxorubicin—liver cancer	0.0104	0.0359	CbGbCtD
Tamoxifen—ABCB11—Doxorubicin—liver cancer	0.0104	0.0359	CbGbCtD
Tamoxifen—ABCC2—Sorafenib—liver cancer	0.009	0.0311	CbGbCtD
Tamoxifen—ABCG2—Sorafenib—liver cancer	0.00814	0.0281	CbGbCtD
Tamoxifen—ABCC2—bile canaliculus—liver cancer	0.00665	0.177	CbGeAlD
Tamoxifen—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.00601	0.0208	CbGbCtD
Tamoxifen—CYP3A7—Sorafenib—liver cancer	0.00601	0.0208	CbGbCtD
Tamoxifen—CYP2B6—Sorafenib—liver cancer	0.00573	0.0198	CbGbCtD
Tamoxifen—ABCC2—Doxorubicin—liver cancer	0.00546	0.0189	CbGbCtD
Tamoxifen—ABCG2—Doxorubicin—liver cancer	0.00494	0.0171	CbGbCtD
Tamoxifen—CYP3A5—Sorafenib—liver cancer	0.00451	0.0156	CbGbCtD
Tamoxifen—CYP2C8—Sorafenib—liver cancer	0.00434	0.015	CbGbCtD
Tamoxifen—ABCB11—bile duct—liver cancer	0.00408	0.109	CbGeAlD
Tamoxifen—CYP2C19—Sorafenib—liver cancer	0.00364	0.0126	CbGbCtD
Tamoxifen—CYP2B6—Doxorubicin—liver cancer	0.00347	0.012	CbGbCtD
Tamoxifen—CYP1A2—Sorafenib—liver cancer	0.00336	0.0116	CbGbCtD
Tamoxifen—ABCB11—bile—liver cancer	0.00314	0.0837	CbGeAlD
Tamoxifen—CYP2C9—Sorafenib—liver cancer	0.00302	0.0105	CbGbCtD
Tamoxifen—ABCB1—Sorafenib—liver cancer	0.00294	0.0101	CbGbCtD
Tamoxifen—CYP2D6—Sorafenib—liver cancer	0.00277	0.00956	CbGbCtD
Tamoxifen—ABCC2—bile duct—liver cancer	0.00208	0.0554	CbGeAlD
Tamoxifen—ABCB1—Doxorubicin—liver cancer	0.00178	0.00616	CbGbCtD
Tamoxifen—CYP3A4—Sorafenib—liver cancer	0.00176	0.00608	CbGbCtD
Tamoxifen—CYP2D6—Doxorubicin—liver cancer	0.00168	0.0058	CbGbCtD
Tamoxifen—ABCC2—bile—liver cancer	0.0016	0.0426	CbGeAlD
Tamoxifen—CYP3A4—Doxorubicin—liver cancer	0.00107	0.00369	CbGbCtD
Tamoxifen—CES1—gall bladder—liver cancer	0.00068	0.0181	CbGeAlD
Tamoxifen—EBPL—liver—liver cancer	0.000517	0.0138	CbGeAlD
Tamoxifen—EBP—liver—liver cancer	0.000496	0.0132	CbGeAlD
Tamoxifen—SULT1A1—liver—liver cancer	0.000411	0.011	CbGeAlD
Tamoxifen—UGT1A4—liver—liver cancer	0.000358	0.00957	CbGeAlD
Tamoxifen—DHCR7—liver—liver cancer	0.000292	0.0078	CbGeAlD
Tamoxifen—FMO1—liver—liver cancer	0.000292	0.0078	CbGeAlD
Tamoxifen—ESRRA—liver—liver cancer	0.000288	0.00768	CbGeAlD
Tamoxifen—ESR1—embryo—liver cancer	0.000256	0.00682	CbGeAlD
Tamoxifen—ABCB11—liver—liver cancer	0.000255	0.00682	CbGeAlD
Tamoxifen—FMO3—liver—liver cancer	0.000253	0.00674	CbGeAlD
Tamoxifen—CYP3A7—liver—liver cancer	0.00025	0.00667	CbGeAlD
Tamoxifen—CYP3A7-CYP3A51P—liver—liver cancer	0.000212	0.00567	CbGeAlD
Tamoxifen—CES1—liver—liver cancer	0.000199	0.00532	CbGeAlD
Tamoxifen—Diethylstilbestrol—ESR1—liver cancer	0.000195	0.16	CrCbGaD
Tamoxifen—Ospemifene—ESR1—liver cancer	0.000189	0.156	CrCbGaD
Tamoxifen—Blister—Epirubicin—liver cancer	0.000179	0.00383	CcSEcCtD
Tamoxifen—Hyperlipidaemia—Epirubicin—liver cancer	0.000179	0.00383	CcSEcCtD
Tamoxifen—Cyst—Doxorubicin—liver cancer	0.000179	0.00382	CcSEcCtD
Tamoxifen—Redness—Doxorubicin—liver cancer	0.000177	0.00378	CcSEcCtD
Tamoxifen—Haemoglobin—Sorafenib—liver cancer	0.000177	0.00377	CcSEcCtD
Tamoxifen—Haemorrhage—Sorafenib—liver cancer	0.000176	0.00375	CcSEcCtD
Tamoxifen—Vaginal haemorrhage—Epirubicin—liver cancer	0.000175	0.00373	CcSEcCtD
Tamoxifen—CYP2A6—liver—liver cancer	0.000174	0.00463	CbGeAlD
Tamoxifen—ESR2—liver—liver cancer	0.000173	0.00461	CbGeAlD
Tamoxifen—Paralysis—Doxorubicin—liver cancer	0.000172	0.00367	CcSEcCtD
Tamoxifen—Hypercalcaemia—Doxorubicin—liver cancer	0.000172	0.00367	CcSEcCtD
Tamoxifen—Thrombosis—Doxorubicin—liver cancer	0.000169	0.00361	CcSEcCtD
Tamoxifen—Erythema multiforme—Sorafenib—liver cancer	0.000166	0.00354	CcSEcCtD
Tamoxifen—Blister—Doxorubicin—liver cancer	0.000166	0.00354	CcSEcCtD
Tamoxifen—Hyperlipidaemia—Doxorubicin—liver cancer	0.000166	0.00354	CcSEcCtD
Tamoxifen—Flushing—Sorafenib—liver cancer	0.000163	0.00348	CcSEcCtD
Tamoxifen—Vaginal haemorrhage—Doxorubicin—liver cancer	0.000162	0.00345	CcSEcCtD
Tamoxifen—Diethylstilbestrol—CYP2E1—liver cancer	0.000158	0.13	CrCbGaD
Tamoxifen—Arrhythmia—Sorafenib—liver cancer	0.000157	0.00335	CcSEcCtD
Tamoxifen—Alopecia—Sorafenib—liver cancer	0.000155	0.00331	CcSEcCtD
Tamoxifen—Toremifene—ESR1—liver cancer	0.000154	0.127	CrCbGaD
Tamoxifen—Liver injury—Epirubicin—liver cancer	0.000154	0.00328	CcSEcCtD
Tamoxifen—Erythema—Sorafenib—liver cancer	0.000153	0.00326	CcSEcCtD
Tamoxifen—Dysgeusia—Sorafenib—liver cancer	0.00015	0.0032	CcSEcCtD
Tamoxifen—Breast pain—Epirubicin—liver cancer	0.000148	0.00316	CcSEcCtD
Tamoxifen—Amenorrhoea—Epirubicin—liver cancer	0.000147	0.00314	CcSEcCtD
Tamoxifen—Cardiovascular disorder—Epirubicin—liver cancer	0.000147	0.00314	CcSEcCtD
Tamoxifen—Muscle spasms—Sorafenib—liver cancer	0.000147	0.00314	CcSEcCtD
Tamoxifen—Arthropathy—Epirubicin—liver cancer	0.000142	0.00303	CcSEcCtD
Tamoxifen—Liver injury—Doxorubicin—liver cancer	0.000142	0.00303	CcSEcCtD
Tamoxifen—Anaemia—Sorafenib—liver cancer	0.000141	0.00302	CcSEcCtD
Tamoxifen—Cough increased—Epirubicin—liver cancer	0.000141	0.00301	CcSEcCtD
Tamoxifen—Angioedema—Sorafenib—liver cancer	0.00014	0.00298	CcSEcCtD
Tamoxifen—Breast pain—Doxorubicin—liver cancer	0.000137	0.00293	CcSEcCtD
Tamoxifen—Leukopenia—Sorafenib—liver cancer	0.000137	0.00292	CcSEcCtD
Tamoxifen—Blood bilirubin increased—Epirubicin—liver cancer	0.000137	0.00292	CcSEcCtD
Tamoxifen—Amenorrhoea—Doxorubicin—liver cancer	0.000136	0.00291	CcSEcCtD
Tamoxifen—Cardiovascular disorder—Doxorubicin—liver cancer	0.000136	0.00291	CcSEcCtD
Tamoxifen—CYP19A1—liver—liver cancer	0.000136	0.00363	CbGeAlD
Tamoxifen—Creatinine increased—Epirubicin—liver cancer	0.000136	0.0029	CcSEcCtD
Tamoxifen—Bone pain—Epirubicin—liver cancer	0.000135	0.00288	CcSEcCtD
Tamoxifen—SIGMAR1—liver—liver cancer	0.000134	0.00357	CbGeAlD
Tamoxifen—Cough—Sorafenib—liver cancer	0.000133	0.00285	CcSEcCtD
Tamoxifen—Clomifene—ESR1—liver cancer	0.000133	0.11	CrCbGaD
Tamoxifen—Inflammation—Epirubicin—liver cancer	0.000133	0.00284	CcSEcCtD
Tamoxifen—Gait disturbance—Epirubicin—liver cancer	0.000132	0.00283	CcSEcCtD
Tamoxifen—Hypertension—Sorafenib—liver cancer	0.000132	0.00282	CcSEcCtD
Tamoxifen—Arthropathy—Doxorubicin—liver cancer	0.000132	0.00281	CcSEcCtD
Tamoxifen—Musculoskeletal pain—Epirubicin—liver cancer	0.000131	0.00279	CcSEcCtD
Tamoxifen—Cough increased—Doxorubicin—liver cancer	0.000131	0.00279	CcSEcCtD
Tamoxifen—Myalgia—Sorafenib—liver cancer	0.00013	0.00278	CcSEcCtD
Tamoxifen—Arthralgia—Sorafenib—liver cancer	0.00013	0.00278	CcSEcCtD
Tamoxifen—ABCC2—liver—liver cancer	0.00013	0.00347	CbGeAlD
Tamoxifen—Pulmonary embolism—Epirubicin—liver cancer	0.000129	0.00276	CcSEcCtD
Tamoxifen—Vaginal inflammation—Epirubicin—liver cancer	0.000129	0.00276	CcSEcCtD
Tamoxifen—Hepatocellular injury—Epirubicin—liver cancer	0.000129	0.00276	CcSEcCtD
Tamoxifen—Dry mouth—Sorafenib—liver cancer	0.000127	0.00272	CcSEcCtD
Tamoxifen—CYP1B1—liver—liver cancer	0.000127	0.00339	CbGeAlD
Tamoxifen—Blood bilirubin increased—Doxorubicin—liver cancer	0.000126	0.0027	CcSEcCtD
Tamoxifen—Creatinine increased—Doxorubicin—liver cancer	0.000126	0.00268	CcSEcCtD
Tamoxifen—Bone pain—Doxorubicin—liver cancer	0.000125	0.00266	CcSEcCtD
Tamoxifen—Infection—Sorafenib—liver cancer	0.000124	0.00265	CcSEcCtD
Tamoxifen—Skin exfoliation—Epirubicin—liver cancer	0.000123	0.00263	CcSEcCtD
Tamoxifen—Toremifene—CYP1A1—liver cancer	0.000123	0.101	CrCbGaD
Tamoxifen—Inflammation—Doxorubicin—liver cancer	0.000123	0.00263	CcSEcCtD
Tamoxifen—Fluid retention—Epirubicin—liver cancer	0.000123	0.00262	CcSEcCtD
Tamoxifen—Gait disturbance—Doxorubicin—liver cancer	0.000123	0.00262	CcSEcCtD
Tamoxifen—Thrombocytopenia—Sorafenib—liver cancer	0.000122	0.00261	CcSEcCtD
Tamoxifen—Vaginal infection—Epirubicin—liver cancer	0.000122	0.0026	CcSEcCtD
Tamoxifen—Musculoskeletal pain—Doxorubicin—liver cancer	0.000121	0.00258	CcSEcCtD
Tamoxifen—Pulmonary embolism—Doxorubicin—liver cancer	0.00012	0.00255	CcSEcCtD
Tamoxifen—Vaginal inflammation—Doxorubicin—liver cancer	0.00012	0.00255	CcSEcCtD
Tamoxifen—Hepatocellular injury—Doxorubicin—liver cancer	0.00012	0.00255	CcSEcCtD
Tamoxifen—Anorexia—Sorafenib—liver cancer	0.000119	0.00254	CcSEcCtD
Tamoxifen—Cramps of lower extremities—Epirubicin—liver cancer	0.000119	0.00253	CcSEcCtD
Tamoxifen—ESR1—liver—liver cancer	0.000118	0.00316	CbGeAlD
Tamoxifen—Neoplasm—Epirubicin—liver cancer	0.000117	0.00249	CcSEcCtD
Tamoxifen—Skin exfoliation—Doxorubicin—liver cancer	0.000114	0.00244	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000114	0.00243	CcSEcCtD
Tamoxifen—Fluid retention—Doxorubicin—liver cancer	0.000114	0.00242	CcSEcCtD
Tamoxifen—Vaginal infection—Doxorubicin—liver cancer	0.000113	0.00241	CcSEcCtD
Tamoxifen—Sepsis—Epirubicin—liver cancer	0.000112	0.00239	CcSEcCtD
Tamoxifen—CYP2C19—liver—liver cancer	0.000112	0.00298	CbGeAlD
Tamoxifen—Dyspnoea—Sorafenib—liver cancer	0.000111	0.00237	CcSEcCtD
Tamoxifen—Cramps of lower extremities—Doxorubicin—liver cancer	0.00011	0.00234	CcSEcCtD
Tamoxifen—Dyspepsia—Sorafenib—liver cancer	0.00011	0.00234	CcSEcCtD
Tamoxifen—Decreased appetite—Sorafenib—liver cancer	0.000108	0.00232	CcSEcCtD
Tamoxifen—Neoplasm—Doxorubicin—liver cancer	0.000108	0.00231	CcSEcCtD
Tamoxifen—Clomifene—CYP2E1—liver cancer	0.000108	0.0889	CrCbGaD
Tamoxifen—Gastrointestinal disorder—Sorafenib—liver cancer	0.000108	0.0023	CcSEcCtD
Tamoxifen—Fatigue—Sorafenib—liver cancer	0.000108	0.0023	CcSEcCtD
Tamoxifen—Hepatic function abnormal—Epirubicin—liver cancer	0.000107	0.00229	CcSEcCtD
Tamoxifen—Pain—Sorafenib—liver cancer	0.000107	0.00228	CcSEcCtD
Tamoxifen—Constipation—Sorafenib—liver cancer	0.000107	0.00228	CcSEcCtD
Tamoxifen—Clomifene—CYP1A1—liver cancer	0.000107	0.0877	CrCbGaD
Tamoxifen—Hepatic failure—Epirubicin—liver cancer	0.000104	0.00223	CcSEcCtD
Tamoxifen—Sepsis—Doxorubicin—liver cancer	0.000104	0.00222	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Sorafenib—liver cancer	0.000102	0.00218	CcSEcCtD
Tamoxifen—ABCB1—embryo—liver cancer	0.000101	0.00269	CbGeAlD
Tamoxifen—Hot flush—Epirubicin—liver cancer	0.0001	0.00214	CcSEcCtD
Tamoxifen—Menopausal symptoms—Epirubicin—liver cancer	9.94e-05	0.00212	CcSEcCtD
Tamoxifen—Hepatic function abnormal—Doxorubicin—liver cancer	9.93e-05	0.00212	CcSEcCtD
Tamoxifen—Urticaria—Sorafenib—liver cancer	9.91e-05	0.00212	CcSEcCtD
Tamoxifen—Abdominal pain—Sorafenib—liver cancer	9.86e-05	0.00211	CcSEcCtD
Tamoxifen—Dermatitis bullous—Epirubicin—liver cancer	9.82e-05	0.0021	CcSEcCtD
Tamoxifen—CYP2C8—liver—liver cancer	9.74e-05	0.0026	CbGeAlD
Tamoxifen—Hepatic failure—Doxorubicin—liver cancer	9.66e-05	0.00206	CcSEcCtD
Tamoxifen—ABCG2—liver—liver cancer	9.47e-05	0.00253	CbGeAlD
Tamoxifen—Osteoarthritis—Epirubicin—liver cancer	9.38e-05	0.002	CcSEcCtD
Tamoxifen—Hot flush—Doxorubicin—liver cancer	9.28e-05	0.00198	CcSEcCtD
Tamoxifen—Menopausal symptoms—Doxorubicin—liver cancer	9.2e-05	0.00196	CcSEcCtD
Tamoxifen—Hypersensitivity—Sorafenib—liver cancer	9.19e-05	0.00196	CcSEcCtD
Tamoxifen—CYP1A2—liver—liver cancer	9.11e-05	0.00243	CbGeAlD
Tamoxifen—Dermatitis bullous—Doxorubicin—liver cancer	9.08e-05	0.00194	CcSEcCtD
Tamoxifen—CYP1A1—liver—liver cancer	8.99e-05	0.0024	CbGeAlD
Tamoxifen—Asthenia—Sorafenib—liver cancer	8.95e-05	0.00191	CcSEcCtD
Tamoxifen—Mood swings—Epirubicin—liver cancer	8.89e-05	0.0019	CcSEcCtD
Tamoxifen—Pruritus—Sorafenib—liver cancer	8.83e-05	0.00188	CcSEcCtD
Tamoxifen—CYP3A5—liver—liver cancer	8.79e-05	0.00235	CbGeAlD
Tamoxifen—Blood creatinine increased—Epirubicin—liver cancer	8.79e-05	0.00188	CcSEcCtD
Tamoxifen—CYP2B6—liver—liver cancer	8.74e-05	0.00233	CbGeAlD
Tamoxifen—Osteoarthritis—Doxorubicin—liver cancer	8.68e-05	0.00185	CcSEcCtD
Tamoxifen—Liver function test abnormal—Epirubicin—liver cancer	8.66e-05	0.00185	CcSEcCtD
Tamoxifen—CYP2C9—liver—liver cancer	8.65e-05	0.00231	CbGeAlD
Tamoxifen—Diarrhoea—Sorafenib—liver cancer	8.54e-05	0.00182	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Epirubicin—liver cancer	8.45e-05	0.0018	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Epirubicin—liver cancer	8.28e-05	0.00177	CcSEcCtD
Tamoxifen—Dizziness—Sorafenib—liver cancer	8.25e-05	0.00176	CcSEcCtD
Tamoxifen—Mood swings—Doxorubicin—liver cancer	8.22e-05	0.00176	CcSEcCtD
Tamoxifen—CYP2E1—liver—liver cancer	8.2e-05	0.00219	CbGeAlD
Tamoxifen—Blood creatinine increased—Doxorubicin—liver cancer	8.13e-05	0.00174	CcSEcCtD
Tamoxifen—Influenza—Epirubicin—liver cancer	8.11e-05	0.00173	CcSEcCtD
Tamoxifen—Dysphagia—Epirubicin—liver cancer	8.11e-05	0.00173	CcSEcCtD
Tamoxifen—Liver function test abnormal—Doxorubicin—liver cancer	8.02e-05	0.00171	CcSEcCtD
Tamoxifen—Pancreatitis—Epirubicin—liver cancer	7.95e-05	0.0017	CcSEcCtD
Tamoxifen—Vomiting—Sorafenib—liver cancer	7.93e-05	0.00169	CcSEcCtD
Tamoxifen—Angina pectoris—Epirubicin—liver cancer	7.9e-05	0.00169	CcSEcCtD
Tamoxifen—Rash—Sorafenib—liver cancer	7.87e-05	0.00168	CcSEcCtD
Tamoxifen—Dermatitis—Sorafenib—liver cancer	7.86e-05	0.00168	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Doxorubicin—liver cancer	7.82e-05	0.00167	CcSEcCtD
Tamoxifen—Headache—Sorafenib—liver cancer	7.82e-05	0.00167	CcSEcCtD
Tamoxifen—Bronchitis—Epirubicin—liver cancer	7.8e-05	0.00166	CcSEcCtD
Tamoxifen—Pancytopenia—Epirubicin—liver cancer	7.7e-05	0.00164	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Doxorubicin—liver cancer	7.66e-05	0.00163	CcSEcCtD
Tamoxifen—Neutropenia—Epirubicin—liver cancer	7.58e-05	0.00162	CcSEcCtD
Tamoxifen—Dysphagia—Doxorubicin—liver cancer	7.5e-05	0.0016	CcSEcCtD
Tamoxifen—Influenza—Doxorubicin—liver cancer	7.5e-05	0.0016	CcSEcCtD
Tamoxifen—Nausea—Sorafenib—liver cancer	7.41e-05	0.00158	CcSEcCtD
Tamoxifen—Weight increased—Epirubicin—liver cancer	7.38e-05	0.00158	CcSEcCtD
Tamoxifen—Pancreatitis—Doxorubicin—liver cancer	7.36e-05	0.00157	CcSEcCtD
Tamoxifen—Weight decreased—Epirubicin—liver cancer	7.34e-05	0.00157	CcSEcCtD
Tamoxifen—Angina pectoris—Doxorubicin—liver cancer	7.31e-05	0.00156	CcSEcCtD
Tamoxifen—Pneumonia—Epirubicin—liver cancer	7.27e-05	0.00155	CcSEcCtD
Tamoxifen—Bronchitis—Doxorubicin—liver cancer	7.22e-05	0.00154	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Epirubicin—liver cancer	7.17e-05	0.00153	CcSEcCtD
Tamoxifen—Pancytopenia—Doxorubicin—liver cancer	7.13e-05	0.00152	CcSEcCtD
Tamoxifen—Urinary tract infection—Epirubicin—liver cancer	7.03e-05	0.0015	CcSEcCtD
Tamoxifen—Neutropenia—Doxorubicin—liver cancer	7.02e-05	0.0015	CcSEcCtD
Tamoxifen—Sweating—Epirubicin—liver cancer	6.93e-05	0.00148	CcSEcCtD
Tamoxifen—Weight increased—Doxorubicin—liver cancer	6.83e-05	0.00146	CcSEcCtD
Tamoxifen—Weight decreased—Doxorubicin—liver cancer	6.79e-05	0.00145	CcSEcCtD
Tamoxifen—Sinusitis—Epirubicin—liver cancer	6.78e-05	0.00145	CcSEcCtD
Tamoxifen—Pneumonia—Doxorubicin—liver cancer	6.73e-05	0.00144	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Doxorubicin—liver cancer	6.63e-05	0.00142	CcSEcCtD
Tamoxifen—CYP3A4—liver—liver cancer	6.6e-05	0.00176	CbGeAlD
Tamoxifen—Haemoglobin—Epirubicin—liver cancer	6.52e-05	0.00139	CcSEcCtD
Tamoxifen—Urinary tract infection—Doxorubicin—liver cancer	6.5e-05	0.00139	CcSEcCtD
Tamoxifen—CYP2D6—liver—liver cancer	6.49e-05	0.00173	CbGeAlD
Tamoxifen—Haemorrhage—Epirubicin—liver cancer	6.49e-05	0.00139	CcSEcCtD
Tamoxifen—Hepatitis—Epirubicin—liver cancer	6.49e-05	0.00139	CcSEcCtD
Tamoxifen—Hypoaesthesia—Epirubicin—liver cancer	6.46e-05	0.00138	CcSEcCtD
Tamoxifen—Pharyngitis—Epirubicin—liver cancer	6.44e-05	0.00137	CcSEcCtD
Tamoxifen—Sweating—Doxorubicin—liver cancer	6.41e-05	0.00137	CcSEcCtD
Tamoxifen—Oedema peripheral—Epirubicin—liver cancer	6.39e-05	0.00136	CcSEcCtD
Tamoxifen—Sinusitis—Doxorubicin—liver cancer	6.28e-05	0.00134	CcSEcCtD
Tamoxifen—Visual impairment—Epirubicin—liver cancer	6.26e-05	0.00134	CcSEcCtD
Tamoxifen—Erythema multiforme—Epirubicin—liver cancer	6.14e-05	0.00131	CcSEcCtD
Tamoxifen—Haemoglobin—Doxorubicin—liver cancer	6.04e-05	0.00129	CcSEcCtD
Tamoxifen—Flushing—Epirubicin—liver cancer	6.02e-05	0.00129	CcSEcCtD
Tamoxifen—Haemorrhage—Doxorubicin—liver cancer	6.01e-05	0.00128	CcSEcCtD
Tamoxifen—Hepatitis—Doxorubicin—liver cancer	6.01e-05	0.00128	CcSEcCtD
Tamoxifen—Hypoaesthesia—Doxorubicin—liver cancer	5.98e-05	0.00128	CcSEcCtD
Tamoxifen—Pharyngitis—Doxorubicin—liver cancer	5.96e-05	0.00127	CcSEcCtD
Tamoxifen—Oedema peripheral—Doxorubicin—liver cancer	5.92e-05	0.00126	CcSEcCtD
Tamoxifen—Arrhythmia—Epirubicin—liver cancer	5.8e-05	0.00124	CcSEcCtD
Tamoxifen—Visual impairment—Doxorubicin—liver cancer	5.79e-05	0.00124	CcSEcCtD
Tamoxifen—Alopecia—Epirubicin—liver cancer	5.74e-05	0.00122	CcSEcCtD
Tamoxifen—Erythema multiforme—Doxorubicin—liver cancer	5.68e-05	0.00121	CcSEcCtD
Tamoxifen—Erythema—Epirubicin—liver cancer	5.65e-05	0.00121	CcSEcCtD
Tamoxifen—Flushing—Doxorubicin—liver cancer	5.57e-05	0.00119	CcSEcCtD
Tamoxifen—Dysgeusia—Epirubicin—liver cancer	5.53e-05	0.00118	CcSEcCtD
Tamoxifen—Back pain—Epirubicin—liver cancer	5.47e-05	0.00117	CcSEcCtD
Tamoxifen—Muscle spasms—Epirubicin—liver cancer	5.43e-05	0.00116	CcSEcCtD
Tamoxifen—Arrhythmia—Doxorubicin—liver cancer	5.37e-05	0.00115	CcSEcCtD
Tamoxifen—Alopecia—Doxorubicin—liver cancer	5.31e-05	0.00113	CcSEcCtD
Tamoxifen—Erythema—Doxorubicin—liver cancer	5.23e-05	0.00112	CcSEcCtD
Tamoxifen—Anaemia—Epirubicin—liver cancer	5.22e-05	0.00111	CcSEcCtD
Tamoxifen—Dysgeusia—Doxorubicin—liver cancer	5.12e-05	0.00109	CcSEcCtD
Tamoxifen—Leukopenia—Epirubicin—liver cancer	5.06e-05	0.00108	CcSEcCtD
Tamoxifen—Back pain—Doxorubicin—liver cancer	5.06e-05	0.00108	CcSEcCtD
Tamoxifen—Muscle spasms—Doxorubicin—liver cancer	5.03e-05	0.00107	CcSEcCtD
Tamoxifen—Cough—Epirubicin—liver cancer	4.93e-05	0.00105	CcSEcCtD
Tamoxifen—Hypertension—Epirubicin—liver cancer	4.88e-05	0.00104	CcSEcCtD
Tamoxifen—Orphenadrine—CYP2E1—liver cancer	4.85e-05	0.0399	CrCbGaD
Tamoxifen—Anaemia—Doxorubicin—liver cancer	4.83e-05	0.00103	CcSEcCtD
Tamoxifen—Arthralgia—Epirubicin—liver cancer	4.81e-05	0.00103	CcSEcCtD
Tamoxifen—Chest pain—Epirubicin—liver cancer	4.81e-05	0.00103	CcSEcCtD
Tamoxifen—Myalgia—Epirubicin—liver cancer	4.81e-05	0.00103	CcSEcCtD
Tamoxifen—Anxiety—Epirubicin—liver cancer	4.79e-05	0.00102	CcSEcCtD
Tamoxifen—Discomfort—Epirubicin—liver cancer	4.75e-05	0.00101	CcSEcCtD
Tamoxifen—Dry mouth—Epirubicin—liver cancer	4.7e-05	0.001	CcSEcCtD
Tamoxifen—Leukopenia—Doxorubicin—liver cancer	4.68e-05	0.000999	CcSEcCtD
Tamoxifen—ABCB1—liver—liver cancer	4.67e-05	0.00125	CbGeAlD
Tamoxifen—Oedema—Epirubicin—liver cancer	4.61e-05	0.000984	CcSEcCtD
Tamoxifen—Infection—Epirubicin—liver cancer	4.58e-05	0.000978	CcSEcCtD
Tamoxifen—Cough—Doxorubicin—liver cancer	4.56e-05	0.000974	CcSEcCtD
Tamoxifen—Thrombocytopenia—Epirubicin—liver cancer	4.52e-05	0.000964	CcSEcCtD
Tamoxifen—Hypertension—Doxorubicin—liver cancer	4.51e-05	0.000963	CcSEcCtD
Tamoxifen—Hyperhidrosis—Epirubicin—liver cancer	4.46e-05	0.000951	CcSEcCtD
Tamoxifen—Arthralgia—Doxorubicin—liver cancer	4.45e-05	0.00095	CcSEcCtD
Tamoxifen—Chest pain—Doxorubicin—liver cancer	4.45e-05	0.00095	CcSEcCtD
Tamoxifen—Myalgia—Doxorubicin—liver cancer	4.45e-05	0.00095	CcSEcCtD
Tamoxifen—Anxiety—Doxorubicin—liver cancer	4.44e-05	0.000947	CcSEcCtD
Tamoxifen—Discomfort—Doxorubicin—liver cancer	4.4e-05	0.000939	CcSEcCtD
Tamoxifen—Anorexia—Epirubicin—liver cancer	4.4e-05	0.000938	CcSEcCtD
Tamoxifen—Dry mouth—Doxorubicin—liver cancer	4.35e-05	0.000929	CcSEcCtD
Tamoxifen—Oedema—Doxorubicin—liver cancer	4.27e-05	0.000911	CcSEcCtD
Tamoxifen—Infection—Doxorubicin—liver cancer	4.24e-05	0.000905	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Epirubicin—liver cancer	4.2e-05	0.000897	CcSEcCtD
Tamoxifen—Thrombocytopenia—Doxorubicin—liver cancer	4.18e-05	0.000892	CcSEcCtD
Tamoxifen—Insomnia—Epirubicin—liver cancer	4.17e-05	0.00089	CcSEcCtD
Tamoxifen—Paraesthesia—Epirubicin—liver cancer	4.14e-05	0.000884	CcSEcCtD
Tamoxifen—Hyperhidrosis—Doxorubicin—liver cancer	4.13e-05	0.00088	CcSEcCtD
Tamoxifen—Dyspnoea—Epirubicin—liver cancer	4.11e-05	0.000877	CcSEcCtD
Tamoxifen—Anorexia—Doxorubicin—liver cancer	4.07e-05	0.000868	CcSEcCtD
Tamoxifen—Dyspepsia—Epirubicin—liver cancer	4.06e-05	0.000866	CcSEcCtD
Tamoxifen—Decreased appetite—Epirubicin—liver cancer	4.01e-05	0.000856	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Epirubicin—liver cancer	3.98e-05	0.00085	CcSEcCtD
Tamoxifen—Fatigue—Epirubicin—liver cancer	3.98e-05	0.000849	CcSEcCtD
Tamoxifen—Pain—Epirubicin—liver cancer	3.94e-05	0.000842	CcSEcCtD
Tamoxifen—Constipation—Epirubicin—liver cancer	3.94e-05	0.000842	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Doxorubicin—liver cancer	3.89e-05	0.00083	CcSEcCtD
Tamoxifen—Insomnia—Doxorubicin—liver cancer	3.86e-05	0.000824	CcSEcCtD
Tamoxifen—Paraesthesia—Doxorubicin—liver cancer	3.83e-05	0.000818	CcSEcCtD
Tamoxifen—Dyspnoea—Doxorubicin—liver cancer	3.8e-05	0.000812	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Epirubicin—liver cancer	3.77e-05	0.000805	CcSEcCtD
Tamoxifen—Dyspepsia—Doxorubicin—liver cancer	3.76e-05	0.000802	CcSEcCtD
Tamoxifen—Decreased appetite—Doxorubicin—liver cancer	3.71e-05	0.000792	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Doxorubicin—liver cancer	3.68e-05	0.000786	CcSEcCtD
Tamoxifen—Fatigue—Doxorubicin—liver cancer	3.68e-05	0.000785	CcSEcCtD
Tamoxifen—Urticaria—Epirubicin—liver cancer	3.66e-05	0.000782	CcSEcCtD
Tamoxifen—Pain—Doxorubicin—liver cancer	3.65e-05	0.000779	CcSEcCtD
Tamoxifen—Constipation—Doxorubicin—liver cancer	3.65e-05	0.000779	CcSEcCtD
Tamoxifen—Abdominal pain—Epirubicin—liver cancer	3.65e-05	0.000778	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Doxorubicin—liver cancer	3.49e-05	0.000745	CcSEcCtD
Tamoxifen—Hypersensitivity—Epirubicin—liver cancer	3.4e-05	0.000725	CcSEcCtD
Tamoxifen—Urticaria—Doxorubicin—liver cancer	3.39e-05	0.000723	CcSEcCtD
Tamoxifen—Abdominal pain—Doxorubicin—liver cancer	3.37e-05	0.00072	CcSEcCtD
Tamoxifen—Asthenia—Epirubicin—liver cancer	3.31e-05	0.000706	CcSEcCtD
Tamoxifen—Pruritus—Epirubicin—liver cancer	3.26e-05	0.000696	CcSEcCtD
Tamoxifen—Diarrhoea—Epirubicin—liver cancer	3.16e-05	0.000673	CcSEcCtD
Tamoxifen—Hypersensitivity—Doxorubicin—liver cancer	3.14e-05	0.000671	CcSEcCtD
Tamoxifen—Asthenia—Doxorubicin—liver cancer	3.06e-05	0.000653	CcSEcCtD
Tamoxifen—Dizziness—Epirubicin—liver cancer	3.05e-05	0.000651	CcSEcCtD
Tamoxifen—Pruritus—Doxorubicin—liver cancer	3.02e-05	0.000644	CcSEcCtD
Tamoxifen—Vomiting—Epirubicin—liver cancer	2.93e-05	0.000626	CcSEcCtD
Tamoxifen—Diarrhoea—Doxorubicin—liver cancer	2.92e-05	0.000623	CcSEcCtD
Tamoxifen—Rash—Epirubicin—liver cancer	2.91e-05	0.000621	CcSEcCtD
Tamoxifen—Dermatitis—Epirubicin—liver cancer	2.91e-05	0.00062	CcSEcCtD
Tamoxifen—Headache—Epirubicin—liver cancer	2.89e-05	0.000617	CcSEcCtD
Tamoxifen—Dizziness—Doxorubicin—liver cancer	2.82e-05	0.000602	CcSEcCtD
Tamoxifen—Nausea—Epirubicin—liver cancer	2.74e-05	0.000585	CcSEcCtD
Tamoxifen—Vomiting—Doxorubicin—liver cancer	2.71e-05	0.000579	CcSEcCtD
Tamoxifen—Rash—Doxorubicin—liver cancer	2.69e-05	0.000574	CcSEcCtD
Tamoxifen—Dermatitis—Doxorubicin—liver cancer	2.69e-05	0.000574	CcSEcCtD
Tamoxifen—Headache—Doxorubicin—liver cancer	2.67e-05	0.000571	CcSEcCtD
Tamoxifen—Nausea—Doxorubicin—liver cancer	2.53e-05	0.000541	CcSEcCtD
Tamoxifen—CYP1A1—Metabolism—HMOX1—liver cancer	1.49e-06	2.31e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTA4—liver cancer	1.49e-06	2.3e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.48e-06	2.28e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GSTM1—liver cancer	1.47e-06	2.28e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CD—liver cancer	1.47e-06	2.28e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PPARG—liver cancer	1.47e-06	2.27e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GSTM1—liver cancer	1.47e-06	2.27e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GOT2—liver cancer	1.47e-06	2.27e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP2E1—liver cancer	1.46e-06	2.26e-05	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PIK3CA—liver cancer	1.46e-06	2.26e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PPARG—liver cancer	1.46e-06	2.25e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GOT2—liver cancer	1.45e-06	2.25e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ALB—liver cancer	1.45e-06	2.25e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.45e-06	2.25e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTA2—liver cancer	1.45e-06	2.24e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—HPGDS—liver cancer	1.43e-06	2.22e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CYP1A1—liver cancer	1.43e-06	2.21e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.43e-06	2.2e-05	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—AKT1—liver cancer	1.42e-06	2.2e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KDR—liver cancer	1.41e-06	2.19e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAPK14—liver cancer	1.4e-06	2.17e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYCS—liver cancer	1.4e-06	2.17e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTA1—liver cancer	1.4e-06	2.16e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CYP1A1—liver cancer	1.4e-06	2.16e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CYP1A1—liver cancer	1.39e-06	2.16e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GSTM1—liver cancer	1.39e-06	2.15e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GSTP1—liver cancer	1.39e-06	2.14e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CG—liver cancer	1.38e-06	2.14e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NAT2—liver cancer	1.38e-06	2.14e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.38e-06	2.13e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP2E1—liver cancer	1.38e-06	2.13e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GOT1—liver cancer	1.38e-06	2.13e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GGT1—liver cancer	1.38e-06	2.13e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYCS—liver cancer	1.37e-06	2.12e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP2E1—liver cancer	1.37e-06	2.11e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—HMOX1—liver cancer	1.37e-06	2.11e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—F2—liver cancer	1.36e-06	2.1e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GGT1—liver cancer	1.34e-06	2.08e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GOT1—liver cancer	1.34e-06	2.08e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CD—liver cancer	1.34e-06	2.07e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PPARG—liver cancer	1.34e-06	2.07e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PIK3CB—liver cancer	1.33e-06	2.06e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—MTHFR—liver cancer	1.33e-06	2.06e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CD—liver cancer	1.33e-06	2.05e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALDOB—liver cancer	1.33e-06	2.05e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.32e-06	2.05e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ALB—liver cancer	1.32e-06	2.04e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ALB—liver cancer	1.31e-06	2.03e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PPARA—liver cancer	1.3e-06	2.02e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—MTHFR—liver cancer	1.3e-06	2.01e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CG—liver cancer	1.3e-06	2.01e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—APC—liver cancer	1.3e-06	2.01e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—MTHFR—liver cancer	1.3e-06	2.01e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.3e-06	2.01e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYCS—liver cancer	1.29e-06	2e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CB—liver cancer	1.28e-06	1.98e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.28e-06	1.98e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYCS—liver cancer	1.28e-06	1.98e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PSMA4—liver cancer	1.28e-06	1.98e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PSMD10—liver cancer	1.28e-06	1.98e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PPARA—liver cancer	1.28e-06	1.98e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PPARA—liver cancer	1.28e-06	1.97e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GSTM1—liver cancer	1.27e-06	1.97e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GGT1—liver cancer	1.27e-06	1.96e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GOT1—liver cancer	1.27e-06	1.96e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CRABP1—liver cancer	1.27e-06	1.96e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GGT1—liver cancer	1.26e-06	1.94e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GOT1—liver cancer	1.26e-06	1.94e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GOT2—liver cancer	1.24e-06	1.92e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSTP1—liver cancer	1.24e-06	1.91e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—MTHFR—liver cancer	1.23e-06	1.9e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—BRAF—liver cancer	1.22e-06	1.89e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—HMOX1—liver cancer	1.22e-06	1.89e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CD—liver cancer	1.22e-06	1.88e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTP1—liver cancer	1.21e-06	1.87e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CYP1A1—liver cancer	1.21e-06	1.87e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PPARA—liver cancer	1.2e-06	1.86e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ALB—liver cancer	1.2e-06	1.86e-05	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—AKT1—liver cancer	1.19e-06	1.85e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—HMOX1—liver cancer	1.19e-06	1.84e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP2E1—liver cancer	1.17e-06	1.81e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CB—liver cancer	1.17e-06	1.81e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CB—liver cancer	1.16e-06	1.79e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CD—liver cancer	1.14e-06	1.77e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTP1—liver cancer	1.14e-06	1.76e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSTM1—liver cancer	1.14e-06	1.76e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SERPINE1—liver cancer	1.13e-06	1.75e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.13e-06	1.75e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTP1—liver cancer	1.13e-06	1.74e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—MTHFR—liver cancer	1.13e-06	1.74e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—HMOX1—liver cancer	1.12e-06	1.74e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CG—liver cancer	1.12e-06	1.73e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—HMOX1—liver cancer	1.11e-06	1.72e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTM1—liver cancer	1.11e-06	1.72e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HPGDS—liver cancer	1.11e-06	1.71e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PPARA—liver cancer	1.1e-06	1.71e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MYC—liver cancer	1.1e-06	1.7e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CG—liver cancer	1.09e-06	1.69e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYCS—liver cancer	1.09e-06	1.69e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CG—liver cancer	1.09e-06	1.69e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.08e-06	1.67e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PPARG—liver cancer	1.08e-06	1.67e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYP1A1—liver cancer	1.08e-06	1.67e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PIK3CA—liver cancer	1.08e-06	1.67e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GGT1—liver cancer	1.07e-06	1.66e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GOT1—liver cancer	1.07e-06	1.66e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CB—liver cancer	1.06e-06	1.64e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PPARG—liver cancer	1.06e-06	1.63e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PPARG—liver cancer	1.05e-06	1.63e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP1A1—liver cancer	1.05e-06	1.63e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTM1—liver cancer	1.05e-06	1.62e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTM1—liver cancer	1.04e-06	1.6e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CG—liver cancer	1.03e-06	1.6e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RAF1—liver cancer	1.02e-06	1.58e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—MTHFR—liver cancer	1e-06	1.55e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MTOR—liver cancer	9.98e-07	1.54e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CB—liver cancer	9.98e-07	1.54e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PPARG—liver cancer	9.96e-07	1.54e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.92e-07	1.53e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP1A1—liver cancer	9.91e-07	1.53e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PSMD10—liver cancer	9.86e-07	1.53e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PSMA4—liver cancer	9.86e-07	1.53e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PPARA—liver cancer	9.86e-07	1.52e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP1A1—liver cancer	9.83e-07	1.52e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CD—liver cancer	9.82e-07	1.52e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—MTHFR—liver cancer	9.81e-07	1.52e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ALB—liver cancer	9.7e-07	1.5e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTP1—liver cancer	9.64e-07	1.49e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPARA—liver cancer	9.62e-07	1.49e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CD—liver cancer	9.62e-07	1.49e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CD—liver cancer	9.6e-07	1.48e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GOT2—liver cancer	9.6e-07	1.48e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—HMOX1—liver cancer	9.51e-07	1.47e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ALB—liver cancer	9.5e-07	1.47e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ALB—liver cancer	9.48e-07	1.47e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CG—liver cancer	9.46e-07	1.46e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CDKN1B—liver cancer	9.36e-07	1.45e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—MTHFR—liver cancer	9.24e-07	1.43e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CASP3—liver cancer	9.18e-07	1.42e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL2—liver cancer	9.16e-07	1.42e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—MTHFR—liver cancer	9.16e-07	1.42e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PPARG—liver cancer	9.13e-07	1.41e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CD—liver cancer	9.07e-07	1.4e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPARA—liver cancer	9.07e-07	1.4e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP2E1—liver cancer	9.02e-07	1.39e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPARA—liver cancer	8.99e-07	1.39e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ALB—liver cancer	8.95e-07	1.38e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCND1—liver cancer	8.93e-07	1.38e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—JUN—liver cancer	8.91e-07	1.38e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTM1—liver cancer	8.86e-07	1.37e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.85e-07	1.37e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CTNNB1—liver cancer	8.85e-07	1.37e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—AKT1—liver cancer	8.8e-07	1.36e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MMP9—liver cancer	8.67e-07	1.34e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CDKN1A—liver cancer	8.64e-07	1.34e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CB—liver cancer	8.56e-07	1.32e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CG—liver cancer	8.44e-07	1.31e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYCS—liver cancer	8.44e-07	1.31e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAPK8—liver cancer	8.44e-07	1.3e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP1A1—liver cancer	8.4e-07	1.3e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CB—liver cancer	8.38e-07	1.3e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CB—liver cancer	8.37e-07	1.29e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CD—liver cancer	8.31e-07	1.29e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GGT1—liver cancer	8.28e-07	1.28e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GOT1—liver cancer	8.28e-07	1.28e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CG—liver cancer	8.24e-07	1.27e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ALB—liver cancer	8.21e-07	1.27e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PPARG—liver cancer	8.15e-07	1.26e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PIK3CA—liver cancer	8.13e-07	1.26e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.07e-07	1.25e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPARG—liver cancer	7.95e-07	1.23e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CB—liver cancer	7.91e-07	1.22e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—MTHFR—liver cancer	7.83e-07	1.21e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CA—liver cancer	7.83e-07	1.21e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—liver cancer	7.79e-07	1.2e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CG—liver cancer	7.77e-07	1.2e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—STAT3—liver cancer	7.71e-07	1.19e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CG—liver cancer	7.7e-07	1.19e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPARA—liver cancer	7.68e-07	1.19e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—AKT1—liver cancer	7.64e-07	1.18e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPARG—liver cancer	7.49e-07	1.16e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTP1—liver cancer	7.44e-07	1.15e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPARG—liver cancer	7.43e-07	1.15e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CD—liver cancer	7.42e-07	1.15e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HMOX1—liver cancer	7.34e-07	1.13e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ALB—liver cancer	7.33e-07	1.13e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CB—liver cancer	7.25e-07	1.12e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CD—liver cancer	7.24e-07	1.12e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MYC—liver cancer	7.17e-07	1.11e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ALB—liver cancer	7.15e-07	1.11e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TGFB1—liver cancer	7.15e-07	1.11e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CA—liver cancer	7.12e-07	1.1e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CA—liver cancer	7.06e-07	1.09e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.9e-07	1.07e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTM1—liver cancer	6.84e-07	1.06e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CD—liver cancer	6.83e-07	1.06e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CD—liver cancer	6.77e-07	1.05e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ALB—liver cancer	6.74e-07	1.04e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ALB—liver cancer	6.68e-07	1.03e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—AKT1—liver cancer	6.64e-07	1.03e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KRAS—liver cancer	6.62e-07	1.02e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CG—liver cancer	6.58e-07	1.02e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP1A1—liver cancer	6.48e-07	1e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CB—liver cancer	6.47e-07	1e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CA—liver cancer	6.47e-07	1e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—AKT1—liver cancer	6.39e-07	9.88e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPARG—liver cancer	6.35e-07	9.82e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CB—liver cancer	6.31e-07	9.76e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CA—liver cancer	6.08e-07	9.41e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MTHFR—liver cancer	6.04e-07	9.34e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CB—liver cancer	5.95e-07	9.2e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPARA—liver cancer	5.93e-07	9.17e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CB—liver cancer	5.9e-07	9.12e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—liver cancer	5.88e-07	9.1e-06	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AKT1—liver cancer	5.82e-07	8.99e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CD—liver cancer	5.78e-07	8.94e-06	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AKT1—liver cancer	5.76e-07	8.91e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ALB—liver cancer	5.71e-07	8.83e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HRAS—liver cancer	5.63e-07	8.7e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6—liver cancer	5.39e-07	8.33e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AKT1—liver cancer	5.28e-07	8.17e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CA—liver cancer	5.22e-07	8.07e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CA—liver cancer	5.11e-07	7.9e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CA—liver cancer	5.1e-07	7.89e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CG—liver cancer	5.08e-07	7.85e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CB—liver cancer	5.04e-07	7.79e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKT1—liver cancer	4.97e-07	7.68e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPARG—liver cancer	4.9e-07	7.58e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CA—liver cancer	4.82e-07	7.45e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CD—liver cancer	4.46e-07	6.9e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CA—liver cancer	4.42e-07	6.83e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALB—liver cancer	4.41e-07	6.81e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AKT1—liver cancer	4.26e-07	6.59e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AKT1—liver cancer	4.18e-07	6.46e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AKT1—liver cancer	4.17e-07	6.44e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CA—liver cancer	3.94e-07	6.1e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AKT1—liver cancer	3.94e-07	6.09e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CB—liver cancer	3.89e-07	6.01e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CA—liver cancer	3.85e-07	5.95e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CA—liver cancer	3.63e-07	5.61e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AKT1—liver cancer	3.61e-07	5.58e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CA—liver cancer	3.6e-07	5.56e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AKT1—liver cancer	3.22e-07	4.98e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AKT1—liver cancer	3.14e-07	4.86e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CA—liver cancer	3.07e-07	4.75e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AKT1—liver cancer	2.96e-07	4.58e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AKT1—liver cancer	2.94e-07	4.54e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AKT1—liver cancer	2.51e-07	3.88e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CA—liver cancer	2.37e-07	3.67e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AKT1—liver cancer	1.94e-07	3e-06	CbGpPWpGaD
